Literature DB >> 27908556

The Relationship between Neutrophil-to-Lymphocyte Ratio and Intracerebral Hemorrhage in Type 2 Diabetes Mellitus.

Peng Luo1, Rui Li1, Siyuan Yu1, Tingting Xu1, Shufan Yue1, Yongli Ji1, Xin Chen2, Haiting Xie3.   

Abstract

INTRODUCTION: Chronic systematic inflammation has been suggested to be associated with the occurrence and development of cardiovascular events. Low-grade systematic inflammation persists in type 2 diabetes mellitus (T2DM) patients. In addition, the risk of cerebral hemorrhage in these patients is increased compared with non-diabetic patients. Neutrophil-to-lymphocyte ratio (NLR) is the ratio derived by dividing the neutrophil count with the lymphocyte count from a peripheral blood sample. This study aimed to explore the relation between NLR and cerebral hemorrhage, and to prove that NLR is an independent risk factor of cerebral hemorrhage in T2DM patients.
METHODS: In total, 429 cases of T2DM patients were included. The patients were divided into two groups depending on the presence of cerebral hemorrhage: the cerebral hemorrhage group (n = 87) and the control group (n = 342). Based on clinical and laboratory data of diabetes diagnosis, this article investigates the relationship between NLR and the risk of cerebral hemorrhage.
RESULTS: Increase in NLR was positively correlated with the incidence of cerebral hemorrhage in T2DM patients and might serve as an independent risk factor of cerebral hemorrhage in T2DM patients (OR: 4.451, 95% CI: 2.582-7.672). NLR >2.58 might be useful in predicting the threshold value of cerebral hemorrhage risk in newly diagnosed T2DM patients (area under the curve: .72, 95% CI: .659-.780, P < .001)
CONCLUSION: As an indicator of the degree of systematic inflammation, NLR is an independent risk factor of cerebral hemorrhage in T2DM patients.
Copyright © 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Intracerebral hemorrhage; inflammation; neutrophil-to-lymphocyte ratio; type 2 diabetes mellitus

Mesh:

Year:  2016        PMID: 27908556     DOI: 10.1016/j.jstrokecerebrovasdis.2016.10.041

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  5 in total

1.  Extracellular vesicles derived from bone marrow mesenchymal stem cells alleviate neuroinflammation after diabetic intracerebral hemorrhage via the miR-183-5p/PDCD4/NLRP3 pathway.

Authors:  H Ding; Y Jia; H Lv; W Chang; F Liu; D Wang
Journal:  J Endocrinol Invest       Date:  2021-05-23       Impact factor: 4.256

2.  The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in Type 2 diabetes mellitus.

Authors:  Tingting Xu; Zihua Weng; Chu Pei; Siyuan Yu; Yating Chen; Wenjie Guo; Xingzuo Wang; Peng Luo; Jia Sun
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

3.  Exploration of Noninvasive Detection of Advanced Glycation End Products in the Lens to Screen for Diabetic Kidney Disease.

Authors:  Xue-Meng Zhang; Yuan Gao; Meng-Xue Yang; Xiao-Di Zheng; Rui Zhang; Yue-Yue Wu; Miao Zeng; Qian Yang; Zhi-Yan Yu; Jun Liu; Bing-Bing Zha; Bo Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

4.  Isolated and Combined Effect of Age and Gender on Neutrophil-Lymphocyte Ratio in the Hyperglycemic Saudi Population.

Authors:  Mohammad A Alfhili; Jawaher Alsughayyir; Ahmed Basudan; Hazem K Ghneim; Mourad A M Aboul-Soud; Mohammed Marie; Ayed Dera; Mohammed Alfaifi; Ali G Alkhathami; Zuhier A Awan; Mohammed R Algethami; Yazeed A Al-Sheikh
Journal:  Medicina (Kaunas)       Date:  2022-08-03       Impact factor: 2.948

5.  Early increase of neutrophil-to-lymphocyte ratio predicts 30-day mortality in patients with spontaneous intracerebral hemorrhage.

Authors:  Fei Wang; Feng Xu; Ye Quan; Li Wang; Jian-Jun Xia; Ting-Ting Jiang; Li-Juan Shen; Wen-Hui Kang; Yong Ding; Li-Xia Mei; Xue-Feng Ju; Shan-You Hu; Xiao Wu
Journal:  CNS Neurosci Ther       Date:  2018-05-16       Impact factor: 5.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.